CRP and breast carcinoma: Moreover, a recent study of 84,000 individuals that looked for elevation of three inflammatory biomarkers (CRP, fibrinogen and leukocyte count) observed an increased risk of colorectal, lung and breast cancer, with greatest risk associated with elevation of all three [19].